Skip to main content
MSF logo
  • Media room
  • Contact
  • msf.org
  • About us
    • About the Access Campaign
    • Media room
    • Latest news
    • Jobs

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Our work
    • Drug-resistant infections
    • HIV/AIDS
    • Hepatitis C
    • Patents and intellectual property
      • The Patent Opposisions Database
      • Spotlight on: RCEP trade agreement
    • Research and development
    • Tropical and neglected diseases
      • Spotlight on: Snakebite
    • Tuberculosis
    • Vaccines
      • A Fair Shot campaign
    Wishlist 2019 - Catalogue

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Get involved
    • Campaign success stories
      • A Fair Shot campaign
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    Take Action

    When you join one of our public campaigns, you work with MSF to save lives.

  • Resources
    • Events
    • Feature stories
    • Infographics
    • Interviews
    • Letters
    • Opinion articles
    • Photo stories
    • Press releases
    • Publications
      • Fact sheets
      • Issue briefs
      • Reports
      • Report series
      • Technical briefs
      • All types
    • Research articles
    • Statements
    • Topic overview pages
    • Spotlight pages
    • Videos

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Media room
  • Contact
  • msf.org
  • About us
    • About the Access Campaign
    • Media room
    • Latest news
    • Jobs

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Our work
    • Drug-resistant infections
    • HIV/AIDS
    • Hepatitis C
    • Patents and intellectual property
      • The Patent Opposisions Database
      • Spotlight on: RCEP trade agreement
    • Research and development
    • Tropical and neglected diseases
      • Spotlight on: Snakebite
    • Tuberculosis
    • Vaccines
      • A Fair Shot campaign
    Wishlist 2019 - Catalogue

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

  • Get involved
    • Campaign success stories
      • A Fair Shot campaign
      • Novartis 'Drop the case'
      • Trans-pacific Partnership (TPP)
    Take Action

    When you join one of our public campaigns, you work with MSF to save lives.

  • Resources
    • Events
    • Feature stories
    • Infographics
    • Interviews
    • Letters
    • Opinion articles
    • Photo stories
    • Press releases
    • Publications
      • Fact sheets
      • Issue briefs
      • Reports
      • Report series
      • Technical briefs
      • All types
    • Research articles
    • Statements
    • Topic overview pages
    • Spotlight pages
    • Videos

    Public support helps expand access to life-saving care and treatment.

    Sign up to stay updated and find out how you can get involved.

    I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury

Take action!
Get involved
The existing treatment lasts at least two years including several months in hospital. The treatment at the special drug resistant TB unit on the outskirts of Yerevan means having to take up to 20 pills a day, often together with painful injections every morning.

How is it possible...

...that we sent people to the moon almost 50 years ago, yet millions of people with tuberculosis are still treated with old, inadequate medicines?

https://tbsummit.msfaccess.org/
  • 5 results found
  • There are 2 active filters
  • Clear all filters
  • Pan American Health Organization
  • Tropical & neglected diseases
Filter by
Filters
Filter results

Date

Primary topics

All topics
  • Research and development (1)
  • Tropical & neglected diseases (5)

Types of content

All types
  • Feature story (1)
  • Issue brief (1)
  • Opinion article (1)
  • Press release (2)

Products

All products
  • benznidazole (5)

Diseases

All diseases
  • neglected diseases (2)

General Terms

All terms
  • research and development (R&D) (1)

Geography

All locations
  • Brazil (5)
  • Paraguay (1)

Institutions & Events

All events and institutions
  • Bayer (1)
  • Bill & Melinda Gates Foundation (3)
  • DNDi (23)
  • Gilead (3)
  • GlaxoSmithKline (2)
  • Health Action International (1)
  • ICASA (7)
  • Novartis (1)
  • Oxford University (1)
  • Pan American Health Organization (5)
  • Pfizer (1)
  • Roche (1)
  • Sanofi (2)
  • UNICEF (1)
  • USAID (1)
  • WHO Executive Board (3)
  • World AIDS Day (1)
  • World Health Assembly (13)
  • World Health Organization (34)
Apply
Clear all filters
5 results found
Opinion article |
13 April 2012

Chagas: Making a noise about the ‘silent disease’

Tags
Tropical & neglected diseases benznidazole research and development (R&D) DNDiPan American Health Organization Brazil
Feature story |
09 April 2012

Critical shortage of first-line therapy for Chagas: The story of benznidazole

Tags
Intellectual property and tradeTropical & neglected diseases benznidazole Pan American Health OrganizationRoche Brazil
Press release |
19 March 2012

Argentina joins Brazil in producing life-saving drug for neglected disease

Tags
Intellectual property and tradeTropical & neglected diseases benznidazole Pan American Health Organization Brazil
MSF104225
Press release |
04 October 2011

Treatment Ends for Chagas Patients

Tags
Intellectual property and tradeTropical & neglected diseases neglected diseases benznidazole Pan American Health OrganizationWorld Health Organization BrazilParaguay
Issue brief |
04 October 2011

The shortage of benznidazole leaves thousands of Chagas patients without treatment

Tags
Intellectual property and tradeTropical & neglected diseases neglected diseases benznidazole Pan American Health Organization Brazil

Navigate

  • About the Access Campaign
  • Contact
  • Contact us
  • Get involved
  • Our work
  • Resources
  • Search

Get updates

  • Sign up for our newsletter
  • Privacy & data protection information

Contact

MSF Access Campaign
Médecins Sans Frontières
Rue de Lausanne 78
P.O Box 1016
CH-1211 Geneva 1, Switzerland
Phone:+41 22 849 8484 Fax:+41 22 849 8404
E-mail: access(at)msf.org

Follow us on Twitter and Facebook

  • Facebook
  • Twitter
  • Vimeo
Medicines Shouldn't Be A Luxury